Research Article
Evaluation of Subchronic Toxicity and Genotoxicity of Ethanolic Extract of Aster glehni Leaves and Stems
Table 6
Results of bacterial reverse mutation assay.
| Test article | Dose (μg/plate) | Colonies/plate [factor]a | TA98 | TA100 | TA1535 | TA1537 | WP2 uvrA | −S9 mix | +S9 mix | −S9 mix | +S9 mix | −S9 mix | +S9 mix | −S9 mix | +S9 mix | −S9 mix | +S9 mix |
| EAG | 0 | 26 ± 4 | 25 ± 3 | 114 ± 8 | 107 ± 9 | 14 ± 2 | 15 ± 2 | 15 ± 2 | 15 ± 2 | 22 ± 3 | 29 ± 4 | — | — | — | — | — | — | — | — | — | — | 50 | 25 ± 6 | 28 ± 3 | 111 ± 6 | 102 ± 9 | 12 ± 4 | 16 ± 5 | 13 ± 2 | 13 ± 3 | 22 ± 4 | 25 ± 4 | [1.0] | [1.1] | [1.0] | [0.9] | [0.9] | [1.1] | [0.9] | [0.9] | [1.0] | [0.9] | 150 | 27 ± 4 | 30 ± 5 | 107 ± 15 | 120 ± 16 | 10 ± 1 | 15 ± 1 | 15 ± 1 | 12 ± 3 | 18 ± 3 | 26 ± 7 | [1.1] | [1.2] | [0.9] | [1.1] | [0.8] | [1.0] | [1.0] | [0.8] | [0.8] | [0.9] | 500 | 34 ± 5 | 34 ± 4 | 103 ± 7 | 105 ± 5 | 13 ± 1 | 17 ± 1 | 13 ± 1 | 14 ± 1 | 20 ± 2 | 26 ± 6 | [1.3] | [1.4] | [0.9] | [1.0] | [1.0] | [1.1] | [0.9] | [1.0] | [0.9] | [0.9] | 1,500 | 26 ± 5 | 40 ± 3 | 109 ± 6 | 120 ± 10 | 11 ± 1 | 15 ± 2 | 12 ± 2 | 13 ± 2 | 23 ± 4 | 26 ± 4 | [1.0] | [1.6] | [1.0] | [1.1] | [0.8] | [1.0] | [0.8] | [0.9] | [1.0] | [0.9] | 3,000 | 34 ± 5 | 56 ± 5 | 121 ± 2 | 137 ± 1 | 13 ± 2 | 13 ± 3 | 13 ± 3 | 17 ± 3 | 22 ± 2 | 27 ± 2 | [1.3] | [2.3] | [1.1] | [1.3] | [0.9] | [0.9] | [0.9] | [1.2] | [1.0] | [0.9] | 5,000 | 34 ± 2 | 63 ± 6 | 116 ± 12 | 137 ± 3 | 13 ± 1 | 13 ± 1 | 12 ± 2 | 20 ± 1 | 25 ± 2 | 23 ± 3 | [1.3] | [2.5] | [1.0] | [1.3] | [0.9] | [0.8] | [0.8] | [1.3] | [1.1] | [0.8] | Positive controlb | 225 ± 16 | 118 ± 8 | 465 ± 60 | 1504 ± 102 | 408 ± 12 | 142 ± 19 | 265 ± 20 | 182 ± 22 | 227 ± 25 | 104 ± 8 | [8.8] | [4.8] | [4.1] | [14.0] | [29.9] | [9.3] | [18.1] | [12.1] | [10.3] | [3.6] |
|
|
Data are expressed as mean ± standard deviation. aThree plates were used each dose. Factor = no. of colonies of treated plate/no. of colonies of negative control plate. bTA98: 2-NF 2 μg/plate (−S9 mix), B[a]P 1 μg/plate (+S9 mix); TA100:SA 0.5 μg/plate (−S9 mix), 2-AA 1 μg/plate (+S9 mix); TA1535:SA 0.5 μg/plate (−S9 mix), 2-AA 2 μg/plate (+S9 mix); TA1537:ICR-191 0.5 μg/plate (−S9 mix), 2-AA 1 μg/plate (+S9 mix); and WP2 uvrA:4NQO 0.5 μg/plate (−S9 mix), 2-AA 6 μg/plate (+S9 mix). 2-NF, 2-nitrofluorene; B[a]P, benzo[a]pyrene; SA, sodium azide; 2-AA, 2-aminoanthracene; ICR-191, acridine mutagen ICR 191; and 4NQO, 4-nitroquinoline N-oxide.
|